Drug Approval | March 16, 2022
UFDA approves first generic of Symbicort to treat asthma and COPD
This drug-device combination product is a metered-dose inhaler (MDI), which contains both budesonide (a corticosteroid that reduces inflammation) and formoterol (a long-acting bronchodilator that relaxes muscles in the airways to improve breathing)
